Evaluation of Drug-Induced QT Interval ProlongationImplications for Drug Approval and Labelling

被引：0
|
作者：
Marek Malik
A. John Camm
机构：
[1] St George’s Hospital Medical School,Department of Cardiological Sciences
来源：
Drug Safety | 2001年 / 24卷
关键词：
Moxifloxacin; Cisapride; Terfenadine; Cardiac Toxicity; Sparfloxacin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Assessment of proarrhythmic toxicity of newly developed drugs attracts significant attention from drug developers and regulatory agencies. Although no guidelines exist for such assessment, the present experience allows several key suggestions to be made and an appropriate technology to be proposed.
引用
收藏
页码：323 / 351
页数：28
相关论文
共 50 条
  • [21] Drug-induced prolongation of the OT interval: regulatory dilemmas and implications for approval and labelling of a new chemical entity
    Shah, RR
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2002, 16 (02) : 147 - 156
  • [22] EVALUATION OF DRUG-INDUCED QT INTERVAL MODIFICATIONS IN DYNAMIC ELECTROCARDIOGRAPHY - THE CASE OF BEPRIDIL
    COUMEL, P
    LECLERCQ, JF
    NADITCH, L
    PELLERIN, D
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1993, 7 (01) : 61 - 68
  • [23] Drug-Induced QT-Interval Prolongation: Considerations for Clinicians
    Li, Edward C.
    Esterly, John S.
    Pohl, Shaunte
    Scott, Shane D.
    McBride, Brian F.
    PHARMACOTHERAPY, 2010, 30 (07): : 684 - 701
  • [24] Genetic and Molecular Aspects of Drug-Induced QT Interval Prolongation
    Baracaldo-Santamaria, Daniela
    Llinas-Caballero, Kevin
    Miguel Corso-Ramirez, Julian
    Martin Restrepo, Carlos
    Alberto Dominguez-Dominguez, Camilo
    Janeth Fonseca-Mendoza, Dora
    Alberto Calderon-Ospina, Carlos
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (15)
  • [25] Drug-induced prolongation of the QT interval: What's the point?
    White, PF
    Abrao, J
    ANESTHESIOLOGY, 2006, 104 (02) : 386 - 387
  • [26] Refining detection of drug-induced proarrhythmia: QT interval and TRIaD
    Shah, RR
    Hondeghem, LM
    HEART RHYTHM, 2005, 2 (07) : 758 - 772
  • [27] Preferred QT correction formula for the assessment of drug-induced QT interval prolongation
    Chiladakis, I.
    Kalogeropoulos, A.
    Arvanitis, P.
    Koutsogiannis, N.
    Zagli, F.
    Alexopoulos, D.
    EUROPEAN HEART JOURNAL, 2010, 31 : 266 - 266
  • [28] Preferred QT Correction Formula for the Assessment of Drug-Induced QT Interval Prolongation
    Chiladakis, John
    Kalogeropoulos, Andreas
    Arvanitis, Panagiotis
    Koutsogiannis, Nikolaos
    Zagli, Fani
    Alexopoulos, Dimitrios
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2010, 21 (08) : 905 - 913
  • [29] Drug-Induced QT Interval Prolongation in Children: Are the Kids Alright?
    Tisdale, James E.
    CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2016, 69 (03): : 183 - 184
  • [30] Drug-induced prolongation of the QT interval: why the regulatory concern?
    Shah, RR
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2002, 16 (02) : 119 - 124
12345